Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Phentermine in Obesity
NCT07870668Phase 4Completed
- Start
- Mar 2024
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of phentermine in obesity (4 arms). Primary endpoint: Relative Percentage Reduction in Total Body Fat at 14 months. Started Mar 2024; status: completed.
02
Drugs
phentermine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07870668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07870668.